Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 1—January 2021
Synopsis

Aspergillosis Complicating Severe Coronavirus Disease

Kieren A. MarrComments to Author , Andrew Platt, Jeffrey A. Tornheim, Sean X. Zhang, Kausik Datta, Celia Cardozo, and Carolina Garcia-Vidal
Author affiliations: Johns Hopkins School of Medicine, Baltimore, Maryland, USA (K.A. Marr, J.A. Tornheim, S.X. Zhang, K. Datta); National Institutes of Health, Bethesda, Maryland, USA (A. Platt); Hospital Clinic of Barcelona, Barcelona, Spain (C. Cardozo, C. Garcia-Vidal)

Main Article

Figure 3

Schematic of coronavirus disease–associated pulmonary aspergillosis. Aspergillus conidia in airway are cleared poorly because of ≥1 defects in primary pulmonary immunity or secondary defenses, enabling conidial germination into hyphal morphotypes, which elicit increased inflammatory responses in the airway and potential invasion into the lungs. A mixed constellation of inflammatory to invasive airway disease, and invasive pulmonary aspergillosis leads to multiple manifestations, including tracheobronchitis and obstructive pneumonia, and complications of invasive fungal pneumonia (nodules, necrosis with cavities, pleural invasion). A) Airways. Aspergillus overgrowth causes pathologic airway inflammation and excess mucous production. B) Alveoli. Hyphal growth causes invasive pneumonia. C) Invasive aspergillosis tracheobronchitis postobstructive bacterial pneumonia.

Figure 3. Schematic of coronavirus disease–associated pulmonary aspergillosis. Aspergillus conidia in airway are cleared poorly because of ≥1 defects in primary pulmonary immunity or secondary defenses, enabling conidial germination into hyphal morphotypes, which elicit increased inflammatory responses in the airway and potential invasion into the lungs. A mixed constellation of inflammatory to invasive airway disease, and invasive pulmonary aspergillosis leads to multiple manifestations, including tracheobronchitis and obstructive pneumonia, and complications of invasive fungal pneumonia (nodules, necrosis with cavities, pleural invasion). A) Airways. Aspergillus overgrowth causes pathologic airway inflammation and excess mucous production. B) Alveoli. Hyphal growth causes invasive pneumonia. C) Invasive aspergillosis tracheobronchitis postobstructive bacterial pneumonia.

Main Article

Page created: September 25, 2020
Page updated: December 21, 2020
Page reviewed: December 21, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external